Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | Clinical implications of cardiac abnormalities detected by cardiac CT

Shan Sui Nio, MD, PhD(c), Amsterdam UMC, Amsterdam, Netherlands, discusses the cardiac abnormalities that can be detected by cardiac CT, and the implications for clinical care. Dr Sui Nio highlights that while previous studies have found associations between these cardiac abnormalities and recurrent ischemic stroke, larger clinical trials are needed to confirm these findings and determine if anticoagulation is beneficial. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yes, so besides cardiac thrombi, cardiac CT also can detect other cardiac abnormalities, such as left atrial appendage slow flow, and as the name implies, it’s a slower flow of the blood in the left atrial appendage, or for example left atrial diverticula, and those are focal outpouches of the left atrial wall so it’s probably caused by a weakness of the diverticular wall so it creates an outpouch...

Yes, so besides cardiac thrombi, cardiac CT also can detect other cardiac abnormalities, such as left atrial appendage slow flow, and as the name implies, it’s a slower flow of the blood in the left atrial appendage, or for example left atrial diverticula, and those are focal outpouches of the left atrial wall so it’s probably caused by a weakness of the diverticular wall so it creates an outpouch. And previous studies have investigated these cardiac structures and they may have found an association with recurrent ischemic stroke at follow-up. But these were mostly investigated in small sample-sized trials. So once these cardiac abnormalities or once these associations are confirmed in larger clinical trials, it may be interesting to see if these patients are likely to benefit from anticoagulation. But previous studies, for example, the NAVIGATE-ESUS or the RESPECT-ESUS, they looked into a stroke of undetermined underlying etiology. And they did not find an effect of anticoagulation. And also the ARCADIA trial, they also looked at patients with ESUS and atrial cardiopathy, and they compared it to patients without atrial cardiopathy. And these results were also neutral in the start of anticoagulation. However, future clinical trials may need to use cardiac CT imaging findings to add to these results to select patients that are more likely to benefit from anticoagulation. So that’s an interesting topic for the future, I think. But first, what we actually first need to do is that we need to create clear imaging definitions on these structures because they can be different between centers in order to create generalizability between different hospitals.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.